Siersted H C, Jensenius J C, Svehag S E, Brandslund I
J Clin Lab Immunol. 1983 Dec;12(4):201-8.
Techniques for the quantification of C3d are shown to estimate the sum of 4 different plasma protein components possessing C3d but not C3c epitopes. All 4 components were C3-derived polypeptides as shown by activating serum containing 125I-labelled C3, isolating the anti-C3d reactive material in 14% PEG supernatant, followed by analysis on SDS-PAGE and autoradiography. Identical results were obtained by radiolabelling 14% PEG plasma supernatants followed by analysis of the anti-C3d reactive material. The components are referred to as d1, d1', d2 and d3 based on their relative electrophoretic mobilities (alpha 1, alpha 1, alpha 2 and alpha 2 respectively) judged by crossed immunoelectrophoresis. Their apparent molecular weights by SDS-PAGE were 129K (d1), 110K (d1'), 46K (d3) and 45K (d2). The possibility that one or more of the C3d containing components represented a complex of a C3 fragment with another plasma protein was investigated. The role of these components in the scheme of the physiological breakdown of C3 and the importance of the individual C3d components as indicators of complement activation in clinical materials is discussed. It is proposed that the 45K d2 component represents a final physiological breakdown product of C3 in human serum.
已证明用于定量C3d的技术可估算4种不同血浆蛋白成分的总和,这些成分具有C3d但不具有C3c表位。如通过激活含有125I标记的C3的血清、在14%聚乙二醇(PEG)上清液中分离抗C3d反应性物质,然后进行SDS-聚丙烯酰胺凝胶电泳(SDS-PAGE)和放射自显影所示,所有4种成分均为C3衍生的多肽。通过对14%PEG血浆上清液进行放射性标记,然后分析抗C3d反应性物质,也获得了相同的结果。根据交叉免疫电泳判断的相对电泳迁移率(分别为α1、α1、α2和α2),这些成分分别称为d1、d1'、d2和d3。通过SDS-PAGE测定,它们的表观分子量分别为129K(d1)、110K(d1')、46K(d3)和45K(d2)。研究了一种或多种含C3d的成分是否代表C3片段与另一种血浆蛋白的复合物。讨论了这些成分在C3生理降解过程中的作用以及各个C3d成分作为临床材料中补体激活指标的重要性。有人提出,45K的d2成分代表人类血清中C3的最终生理降解产物。